Anebulo Pharmaceuticals, Inc.
ANEB
$1.05
-$0.02-1.87%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.06% | -6.57% | -3.45% | 17.73% | 26.92% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 24.54% | 61.07% | 152.65% | 363.72% | 650.94% |
| Total Other Non-Cash Items | -12.57% | 67.37% | 90.64% | 59.41% | 34.50% |
| Change in Net Operating Assets | 303.47% | 532.90% | 138.31% | -76.07% | -16,670.83% |
| Cash from Operations | 12.12% | 15.89% | 21.52% | 24.04% | 30.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -87.02% | -87.02% | 10.64% | 100.00% |
| Cash from Financing | -100.78% | 23,951.44% | 23,951.44% | 11,496.09% | 11,585.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -171.31% | 225.77% | 204.67% | 190.19% | 186.03% |